Dr. Julio Montaner
Fellow
Current Employer
The University of British Columbia
Election Year
2009
Academy
Académie des sciences
Discipline
Medical Sciences
Department
BC Centre for Excellence in HIV/AIDS
Keywords
antiretroviral therapy, HIV, AIDS, Harm Reduction, Injection Drug use
For his pioneering work on the use of combinations of anti-retrovirals to treat HIV/AIDS that led to the first international trial establishing non-nucleoside reverse transcriptase based highly active antiretroviral therapy (HAART) as the standard of care for AIDS and the WHO recommended first line therapy for AIDS in resource limited settings. More recently, he has pioneered the concept pf treatment as prevention as a means to control the spread of HIV worldwide
------------------
MONTANER, Julio –Faculty of Medicine, University of British Columbia
For his pioneering work on the use of combinations of anti-retrovirals to treat HIV/AIDS that led to the first international trial establishing non-nucleoside reverse transcriptase based highly active antiretroviral therapy (HAART) as the standard of care for AIDS and the WHO recommended first line therapy for AIDS in resource limited settings. For introducing the hypothesis that an expanded use of HAART might dramatically curb the growth of the HIV epidemic, while decreasing AIDS morbidity & mortality worldwide.
------------------
MONTANER, Julio –Faculty of Medicine, University of British Columbia
For his pioneering work on the use of combinations of anti-retrovirals to treat HIV/AIDS that led to the first international trial establishing non-nucleoside reverse transcriptase based highly active antiretroviral therapy (HAART) as the standard of care for AIDS and the WHO recommended first line therapy for AIDS in resource limited settings. For introducing the hypothesis that an expanded use of HAART might dramatically curb the growth of the HIV epidemic, while decreasing AIDS morbidity & mortality worldwide.